Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta-analysis

被引:63
|
作者
Lv, Tingting [1 ,2 ,3 ]
Chen, Sha [1 ,2 ,3 ]
Li, Min [4 ]
Zhang, Dong [5 ,6 ,7 ]
Kong, Yuanyuan [4 ]
Jia, Jidong [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing 100050, Peoples R China
[2] Beijing Key Lab Translat Med Liver Cirrhosis, Beijing 100050, Peoples R China
[3] Natl Clin Res Ctr Digest Dis, Beijing 100050, Peoples R China
[4] Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Clin Epidemiol & EBM Unit, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Friendship Hosp, Expt & Translat Res Ctr, Beijing, Peoples R China
[6] Beijing Clin Res Inst, Beijing, Peoples R China
[7] Beijing Key Lab Tolerance Induct & Organ Protect, Beijing, Peoples R China
关键词
epidemiology; incidence; meta-analysis; prevalence; primary biliary cholangitis; PRIMARY SCLEROSING CHOLANGITIS; AUTOIMMUNE LIVER-DISEASE; NATURAL-HISTORY; CLINICAL-FEATURES; RISK-FACTORS; CIRRHOSIS; PREVALENCE; POPULATION; HEPATITIS; VICTORIA;
D O I
10.1111/jgh.15329
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends. Methods: Studies on epidemiology of primary biliary cholangitis (PBC) in PubMed, Embase, and Cochrane Library were systematically retrieved from inception to October 2, 2020. Random-effect model was applied to estimate the pooled PBC incidence and prevalence rates. Subgroup analysis, meta-regression, and sensitivity analysis were conducted to find out the cause for heterogeneity. Results: Out of 3974 records identified through database searching, 47 population-based studies were finally included. The pooled global incidence and prevalence of PBC were 1.76 and 14.60 per 100 000 persons, respectively. Both the PBC incidence and prevalence were lower in the Asia-Pacific region (0.84, 9.82 per 100 000 persons) than that in North America (2.75, 21.81 per 100 000 persons) and Europe (1.86, 14.59 per 100 000 persons) (P < 0.05). The incidence and prevalence showed an increasing tendency in all three regions, with the fastest growth of prevalence in North America (P < 0.05). We found a similar incidence and a lower prevalence of PBC in Northern Europe than that in Southern Europe. A higher incidence and prevalence were observed in female individuals and in the elderly (60-79). Conclusion: The PBC incidence and prevalence varied widely across regions, with North America being the highest, followed by Europe, and the lowest in the Asia-Pacific region. Both the incidence and prevalence showed an increasing tendency worldwide, especially in North America.
引用
收藏
页码:1423 / 1434
页数:12
相关论文
共 50 条
  • [41] Primary biliary cirrhosis and cancer risk: A systematic review and meta-analysis
    Liang, Yan
    Yang, Zaixing
    Zhong, Renqian
    HEPATOLOGY, 2012, 56 (04) : 1409 - 1417
  • [42] OBETICHOLIC ACID VERSUS FIBRATES AS SECOND-LINE THERAPY FOR PRIMARY BILIARY CHOLANGITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    de Abreu, Eliabe S.
    Cavalcante, Deivyd Vieira Silva
    Pitanga, Jorge Ferreira Jasmineiro
    Reginato, Pedro Henrique
    Borges, Pedro Neves
    de Araujo, Yoana Palatianos
    Zarpellon, Loren Angelica
    Santos, Ana Clara Felix de Farias
    Habib, Jaqueline Cardoso
    Cancado, Guilherme
    HEPATOLOGY, 2024, 80 : S1826 - S1827
  • [43] CYCLOSPORINE VERSUS TACROLIMUS AND THE RISK OF PRIMARY BILIARY CHOLANGITIS RECURRENCE AFTER LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hamdeh, Shadi
    Kalot, Mohamad
    Numan, Laith
    Olyaee, Mojtaba S.
    HEPATOLOGY, 2019, 70 : 682A - 682A
  • [44] Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
    Yin, Qin
    Li, Jingjing
    Xia, Yujing
    Zhang, Rong
    Wang, Jianrong
    Lu, Wenxia
    Zhou, Yuqing
    Zheng, Yuanyuan
    Abudumijiti, Huerxidan
    Chen, Rongxia
    Chen, Kan
    Li, Sainan
    Liu, Tong
    Wang, Fan
    Lu, Jie
    Zhou, Yingqun
    Guo, Chuanyong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5407 - 5419
  • [45] The incidence and prevalence of primary biliary cirrhosis: A systematic review and meta-analysis
    Mathivanan, Meena
    Ladak, Farah
    Molodecky, Natalie A.
    Eksteen, Bertus
    Swain, Mark G.
    Kaplan, Gilaad G.
    Myers, Robert P.
    HEPATOLOGY, 2012, 56 : 1140A - 1140A
  • [46] Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis
    Korkmaz, Kerem Sebib
    Steenstraten, Iris
    Trivedi, Palak
    Inderson, Akin
    Van Hoek, Bart
    Girondo, Mar Rodriguez
    Maljaars, Jeroen
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E414 - E414
  • [47] EFFECTS OF SMOKING ON RISK OF PRIMARY SCLEROSING CHOLANGITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rassameehiran, Supannee
    Leelasinjaroen, Pornchai
    Tetangco, Eula
    Sifuentes, Humberto
    GASTROENTEROLOGY, 2018, 154 (06) : S1208 - S1208
  • [48] Immunosuppressive Agents for the Treatment of Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis
    Peng, Xia
    Luo, Xin
    Hou, Jing-Ying
    Wu, Shu-Yun
    Li, Liang-Zong
    Zheng, Ming-Hua
    Wang, Ling-Yun
    DIGESTIVE DISEASES, 2017, 35 (05) : 478 - 485
  • [49] Systematic review and meta-analysis: Transient elastography compared to liver biopsy for staging of liver fibrosis in primary biliary cholangitis
    Antonio Manzo-Francisco, Luis
    Aquino-Matus, Jorge
    Vidana-Perez, Desiree
    Uribe, Misael
    Chavez-Tapia, Norberto
    ANNALS OF HEPATOLOGY, 2023, 28 (04)
  • [50] Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis
    Steenstraten, I.
    Korkmaz, K. Sebib
    Trivedi, P.
    Inderson, A.
    van Hoek, B.
    Girondo, M. Rodriguez
    Maljaars, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S302 - S303